Skip to main content

Juliann Kosovec

House Staff
Surgery

Scholarly Works - Conferences


Evolution in Management of Upfront Treatment For Desmoid Tumors

Conference ANNALS OF SURGICAL ONCOLOGY · March 2023 Link to item Cite

Safety and efficacy of immunotherapy in combination with epigenetic therapy in an esophageal adenocarcinoma model.

Conference Journal of Clinical Oncology · February 1, 2022 335 Background: There is a critical need to develop effective therapeutic approaches for patients with esophageal cancer, a leading cause of cancer mortality. Recently, immune checkpoint blockade (ICB) has demonstrated modest sur ... Full text Cite

The effect of normal, metaplastic, and neoplastic esophageal extracellular matrix upon macrophage activation.

Conference Journal of immunology and regenerative medicine · August 2021 IntroductionMacrophages are capable of extreme plasticity and their activation state has been strongly associated with solid tumor growth progression and regression. Although the macrophage response to extracellular matrix (ECM) isolated from norm ... Full text Cite

Magnitude and duration of immune checkpoint up-regulation and changes in the immune microenvironment post chemo-radiation (CRT) in esophageal cancer.

Conference Journal of Clinical Oncology · May 20, 2017 4060 Background: PD-1 inhibitors in metastatic gastroesophageal cancer have demonstrated response rates of approximately 25%. Unfortunately, the majority of patients do not respond. Therefore, a rationale strategy of combining im ... Full text Cite

Antitumor efficacy of CDK 4/6 dual inhibitor, abemaciclib, in an esophageal adenocarcinoma model.

Conference Journal of Clinical Oncology · May 20, 2017 e15598 Background: Esophageal adenocarcinoma (EAC) is a leading cause of cancer death, and current treatment options are extremely limited. Cell cycle regulators CDK6 and its homolog, CDK4, are known to be up-regulated in EAC and ... Full text Cite

Checkpoint expression pre and post chemoradiation in operable esophageal cancer.

Conference Journal of Clinical Oncology · February 1, 2017 139 Background: PD-L1 expression has been reported in 40% of gastroesophageal cancers, but little data exists with regards to expression of other immune checkpoints. Here, we examined baseline expression levels for multiple immun ... Full text Cite

Role of microbiota and Toll-like receptors in progression of esophageal adenocarcinoma (EAC) in a rat reflux model.

Conference Journal of Clinical Oncology · January 20, 2015 28 Background: The discovery of the link between H. pylori and gastric cancer may be the most direct proof that bacterial signaling and host response can result in carcinogenesis. Accumulating evidence supports that activation of ... Full text Cite

Abstract B05: MRI provides a more reliable method of esophageal tumor detection than endoscopy in a rat model

Conference Molecular Cancer Research · November 1, 2014 AbstractBackground: The surgical rat model of end-to-side esophagojejunal anastomosis has proven utility in terms of its ability to replicate Barrett's carcinogenesis by inducing gastroduodenoesophageal refl ... Full text Cite

Abstract A48: Enhanced efficacy of cisplatin and 5-fluorouracil combination with AUY-922 in esophageal adenocarcinoma cells

Conference Cancer Research · October 1, 2013 AbstractBackground: Esophageal Adenocarcinoma (EAC) continues to rise in incidence, with prognosis remaining poor despite advances in multimodality therapy. Several novel target agents are now being explored ... Full text Cite